STELLARINT is an AI-powered consulting firm dedicated to supporting the biopharmaceutical industry in addressing high-impact strategic questions throughout the product development lifecycle, all with the ultimate goal of enhancing patient outcomes.
Leveraging advanced AI technologies, we employ structured research frameworks to deliver insights that are factually accurate, strategically relevant, and comprehensively analysed.
Our proprietary AI-enabled workflows facilitate rapid, high-quality research across key decision points—from early discovery through to post-launch phases of biopharma product management.
Cardiovascular
Renal and Metabolic disorders (CVRM) - 20 indications
Oncology - 12 indicationsÂ
Immunology & Inflammation (I&I) - 33 indications
Neurology - 11 indications
Respiratory - 10 indications
Ophthalmology - 19 indications